Christine Jessop’s killer identified: Solved cold case raises questions about genetic privacy
By Julia Creet,
The Conversation
| 10. 22. 2020
On Oct. 15, Toronto police announced that they had finally solved the 1984 murder of Christine Jessop using DNA evidence and genetic genealogy websites. Identifying Calvin Hoover as Jessop’s killer has provided immense relief to the family and those close to the case, and in particular to Guy Paul Morin, who was wrongfully convicted and later exonerated after serving 18 months in prison.
The announcement highlights a conundrum: at risk is the genetic privacy of everyone who has uploaded — and, mostly, not uploaded — a DNA sample to a commercial genealogy site.
Genealogists never anticipated that their benign but passionate interest in tracking relations through records and DNA would ever lead to law enforcement’s most potent cold case tool kit. In 2018, public awareness of law enforcement’s mining of genetic genealogy came to light with the 2018 identification of the Golden State Killer. The identification of Joseph James DeAngelo relied on freely uploaded DNA results alongside painstaking genealogical research.
Data industry
Since then, law enforcement’s mining of genealogical data has become an industry in itself, with hundreds...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...